Henry Schein (HS2) Stock Overview
Provides health care products and services to office-based dental and medical practitioners worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
HS2 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Henry Schein, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$63.00 |
| 52 Week High | US$70.34 |
| 52 Week Low | US$52.42 |
| Beta | 0.88 |
| 1 Month Change | 2.07% |
| 3 Month Change | 1.06% |
| 1 Year Change | 10.64% |
| 3 Year Change | -12.01% |
| 5 Year Change | -5.89% |
| Change since IPO | 1,637.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| HS2 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -5.3% | 1.5% | 0.06% |
| 1Y | 10.6% | -6.2% | 1.0% |
Return vs Industry: HS2 exceeded the German Healthcare industry which returned -6.2% over the past year.
Return vs Market: HS2 exceeded the German Market which returned 1% over the past year.
Price Volatility
| HS2 volatility | |
|---|---|
| HS2 Average Weekly Movement | 4.1% |
| Healthcare Industry Average Movement | 6.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in DE Market | 12.3% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: HS2 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: HS2's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1932 | 25,000 | Fred Lowery | www.henryschein.com |
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services.
Henry Schein, Inc. Fundamentals Summary
| HS2 fundamental statistics | |
|---|---|
| Market cap | €7.24b |
| Earnings (TTM) | €339.61m |
| Revenue (TTM) | €11.25b |
Is HS2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HS2 income statement (TTM) | |
|---|---|
| Revenue | US$13.18b |
| Cost of Revenue | US$9.08b |
| Gross Profit | US$4.11b |
| Other Expenses | US$3.71b |
| Earnings | US$398.00m |
Last Reported Earnings
Dec 27, 2025
Next Earnings Date
May 05, 2026
| Earnings per share (EPS) | 3.47 |
| Gross Margin | 31.14% |
| Net Profit Margin | 3.02% |
| Debt/Equity Ratio | 64.7% |
How did HS2 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/03 05:07 |
| End of Day Share Price | 2026/04/30 00:00 |
| Earnings | 2025/12/27 |
| Annual Earnings | 2025/12/27 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Henry Schein, Inc. is covered by 32 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jeffrey Johnson | Baird |
| Glen Santangelo | Barclays |
| Lawrence Marsh | Barclays |